BACHA JEFFREY 4
4 · DelMar Pharmaceuticals, Inc. · Filed Oct 10, 2017
Insider Transaction Report
Form 4
BACHA JEFFREY
CEO and President10% Owner
Transactions
- Purchase
Common Stock
2017-10-06$0.87/sh+7,550$6,569→ 61,247 total - Purchase
Common Stock
2017-10-06$0.88/sh+2,450$2,156→ 63,697 total